¿Emergencia médica?¿Emergencia? Llame al 911. Salas de emergencias más cercanasEmergencias cercanas

Empresa farmacéutica (etiquetadora ante la FDA)

Sun Pharmaceutical Industries, Inc.

Código de etiquetadora NDCs: 10631, 45567, 47335, 49708, 51672, 53489, 57664, 62756, 63304, 70095

¿Qué es una etiquetadora?

La empresa cuyo nombre aparece en el envase y en el directorio de códigos nacionales de medicamentos (NDC) de la FDA. Puede fabricar el medicamento o vender uno fabricado por otra empresa. La primera parte de cada código NDC identifica a la etiquetadora.

Solo datos oficiales de la FDA

Los productos, aprobaciones y retiros vienen de la FDA (directorio NDC, Drugs@FDA, informes de retiros). Los retiros se vinculan a esta empresa por el código NDC del producto retirado.

Si tiene preguntas sobre su medicamento, hable con su médico o farmacéutico. En una emergencia, llame al 911.

De un vistazo

653Productos (NDC)

Medicamentos con receta

Mostrar los otros 190 medicamentos

Solicitudes de la FDA de estos productos

  • NDA: Solicitud de nuevo medicamento (NDA): así se aprueba un medicamento nuevo, normalmente de marca.
  • ANDA: Solicitud abreviada (ANDA): así se aprueba una versión genérica.
  • BLA: Solicitud de licencia de productos biológicos (BLA): así se aprueba un medicamento biológico (hecho a partir de células vivas).
AprobadaSolicitudMedicamentoPatrocinador
31 de agosto de 2026ANDA210232 Pomalidomide
POMALIDOMIDE
Spil
28 de julio de 2026ANDA214319 Sugammadex
SUGAMMADEX SODIUM
Sun Pharm Inds Inc
15 de junio de 2026ANDA219052 Perampanel
PERAMPANEL
Taro
3 de junio de 2026ANDA204196 Dextromethorphan hydrobromide and quinidine sulfate
DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE
Sun Pharm
3 de junio de 2026ANDA218407 Tofacitinib
TOFACITINIB CITRATE
Sun Pharm Inds Inc
28 de abril de 2026ANDA213919 Doxepin hydrochloride
DOXEPIN HYDROCHLORIDE
Sun Pharma Canada
6 de abril de 2026ANDA211491 Dapagliflozin and metformin hydrochloride
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
Sun Pharm
13 de marzo de 2026ANDA216298 Phytonadione
PHYTONADIONE
Orbicular
27 de enero de 2026ANDA219930 Deflazacort
DEFLAZACORT
Sun Pharm Inds Inc
25 de noviembre de 2025ANDA209538 Perampanel
PERAMPANEL
Taro
7 de octubre de 2025ANDA219677 Lamotrigine
LAMOTRIGINE
Taro
26 de agosto de 2025ANDA211123 Macitentan
MACITENTAN
Sun Pharm
6 de agosto de 2025ANDA219058 Doxepin hydrochloride
DOXEPIN HYDROCHLORIDE
Taro
18 de marzo de 2025ANDA217741 Deflazacort
DEFLAZACORT
Sun Pharm
3 de marzo de 2025ANDA208557 Rivaroxaban
RIVAROXABAN
Taro
13 de diciembre de 2024ANDA218858 Lactulose
LACTULOSE
Taro
13 de diciembre de 2024BLA761297 Cosibelimab
UNLOXCYT
Checkpoint Therapeutics Inc
27 de septiembre de 2024NDA213224 Octreotide acetate
BYNFEZIA PEN
Sun Pharm
25 de septiembre de 2024ANDA203857 Glatiramer acetate
GLATIRAMER ACETATE
Synthon Bv
25 de septiembre de 2024ANDA206873 Glatiramer acetate
GLATIRAMER ACETATE
Synthon Bv
25 de julio de 2024NDA217900 Deuruxolitinib phosphate
LEQSELVI
Sun Pharm Inds Inc
14 de junio de 2024ANDA218011 Diclofenac
DICLOFENAC POTASSIUM
Taro
12 de junio de 2024ANDA205470 Acyclovir
ACYCLOVIR
Sun Pharma Canada
19 de marzo de 2024ANDA206431 Sodium sulfate, potassium sulfate, magnesium sulfate
SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE
Taro
18 de enero de 2024ANDA217617 Bisoprolol fumarate
BISOPROLOL FUMARATE
Harman Finochem
Mostrar las otras 100 solicitudes
AprobadaSolicitudMedicamentoPatrocinador
7 de diciembre de 2023ANDA218182 Lidocaine
LIDOCAINE HYDROCHLORIDE
Sun Pharma Canada
19 de octubre de 2023ANDA215837 Pazopanib
PAZOPANIB HYDROCHLORIDE
Sun Pharm
27 de septiembre de 2023ANDA215997 Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Sun Pharm Inds Inc
25 de agosto de 2023ANDA214134 Lisdexamfetamine dimesylate
LISDEXAMFETAMINE DIMESYLATE
Sun Pharm Inds Inc
25 de agosto de 2023ANDA214484 Lisdexamfetamine dimesylate
LISDEXAMFETAMINE DIMESYLATE
Sun Pharm Inds Inc
25 de agosto de 2023ANDA217229 Methylphenidate
METHYLPHENIDATE HYDROCHLORIDE
Sun Pharm Inds Inc
24 de julio de 2023ANDA213458 Bumetanide
BUMETANIDE
Taro
28 de junio de 2023ANDA217594 Sodium bicarbonate
SODIUM BICARBONATE
Steriscience
20 de marzo de 2023ANDA216904 Desmopressin acetate
DESMOPRESSIN ACETATE
Gland
8 de febrero de 2023ANDA211846 Lenalidomide
LENALIDOMIDE
Sun Pharm
5 de enero de 2023ANDA215713 Tretinoin
TRETINOIN
Sun Pharma Canada
17 de noviembre de 2022NDA215910 Phenobarbital sodium
SEZABY
Sun Pharm Inds Inc
16 de noviembre de 2022ANDA216922 Desmopressin acetate
DESMOPRESSIN ACETATE
Gland
29 de septiembre de 2022ANDA208098 Diclofenac
DICLOFENAC SODIUM
Sun Pharma Canada
30 de agosto de 2022ANDA210470 Ciprofloxacin and dexamethasone
CIPROFLOXACIN AND DEXAMETHASONE
Sun Pharm
5 de julio de 2022ANDA212467 Glycopyrrolate
GLYCOPYRROLATE
Cohance Lifesciences
26 de mayo de 2022ANDA215385 Arformoterol tartrate
ARFORMOTEROL TARTRATE
Sun Pharm
18 de mayo de 2022ANDA204400 Pantoprazole sodium
PANTOPRAZOLE SODIUM
Gland
11 de mayo de 2022ANDA214585 Mesalamine
MESALAMINE
Sun Pharm
14 de abril de 2022ANDA215674 Fluphenazine hydrochloride
FLUPHENAZINE HYDROCHLORIDE
Taro
17 de marzo de 2022ANDA205031 Lacosamide
LACOSAMIDE
Sun Pharm
28 de febrero de 2022NDA216018 Ranolazine
ASPRUZYO SPRINKLE
Spil
14 de diciembre de 2021ANDA212514 Amphotericin b
AMPHOTERICIN B
Spil
4 de octubre de 2021ANDA213584 Oxymetazoline hydrochloride
OXYMETAZOLINE HYDROCHLORIDE
Sun Pharma Canada
1 de octubre de 2021ANDA214089 Mexiletine hydrochloride
MEXILETINE HYDROCHLORIDE
Pharmazone
16 de agosto de 2021ANDA213914 Sunitinib malate
SUNITINIB MALATE
Sun Pharm
28 de junio de 2021ANDA214526 Clindamycin
CLINDAMYCIN PHOSPHATE
Sun Pharma Canada
17 de junio de 2021ANDA213906 Levorphanol tartrate
LEVORPHANOL TARTRATE
Sun Pharm Inds Inc
14 de abril de 2021ANDA211922 Budesonide
BUDESONIDE
Sun Pharm
25 de marzo de 2021ANDA214867 Clobetasol propionate
CLOBETASOL PROPIONATE
Sun Pharma Canada
26 de febrero de 2021ANDA212450 Loteprednol etabonate
LOTEPREDNOL ETABONATE
Sun Pharm
18 de febrero de 2021ANDA214384 Droxidopa
DROXIDOPA
Sun Pharm
26 de enero de 2021ANDA205971 Imiquimod
IMIQUIMOD
Taro
15 de enero de 2021ANDA210473 Epoprostenol
EPOPROSTENOL SODIUM
Sun Pharm
10 de noviembre de 2020ANDA214052 Clindamycin
CLINDAMYCIN PHOSPHATE
Sun Pharma Canada
2 de septiembre de 2020ANDA213269 Calcipotriene and betamethasone dipropionate (betamethasone dipropionate / calcipotriene)
CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
Sun Pharma Canada
26 de agosto de 2020NDA213433 Clascoterone
WINLEVI
Sun Pharm
3 de agosto de 2020ANDA212435 Metronidazole
METRONIDAZOLE IN PLASTIC CONTAINER
Gland
10 de julio de 2020ANDA213917 Magnesium sulfate heptahydrate
MAGNESIUM SULFATE IN PLASTIC CONTAINER
Gland
1 de julio de 2020ANDA213046 Butalbital, acetaminophen and caffeine
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
Taro
30 de junio de 2020ANDA213725 Pantoprazole sodium
PANTOPRAZOLE SODIUM
Sun Pharm
17 de junio de 2020ANDA211722 Betamethasone dipropionate
BETAMETHASONE DIPROPIONATE
Sun Pharma Canada
27 de abril de 2020ANDA207116 Mupirocin
MUPIROCIN
Sun Pharma Canada
21 de abril de 2020ANDA206370 Clocortolone pivalate
CLOCORTOLONE PIVALATE
Taro
11 de marzo de 2020ANDA210004 Clindamycin
CLINDAMYCIN PHOSPHATE
Taro
26 de diciembre de 2019ANDA207136 Tobramycin
TOBRAMYCIN
Sun Pharm
4 de diciembre de 2019ANDA208014 Fingolimod
FINGOLIMOD HYDROCHLORIDE
Sun Pharm
29 de noviembre de 2019ANDA091157 Pregabalin
PREGABALIN
Sun Pharm
20 de noviembre de 2019ANDA204024 Fosamprenavir calcium
FOSAMPRENAVIR CALCIUM
Sun Pharm
20 de noviembre de 2019ANDA209782 Deferasirox
DEFERASIROX
Sun Pharm
5 de noviembre de 2019NDA211913 Isotretinoin
ABSORICA LD
Sun Pharm
23 de agosto de 2019ANDA210549 Azelaic acid
AZELAIC ACID
Sun Pharma Canada
19 de agosto de 2019ANDA077674 Pantoprazole sodium
PANTOPRAZOLE SODIUM
Sun Pharm
19 de agosto de 2019ANDA206575 Clindamycin phosphate and benzoyl peroxide
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
Sun Pharma Canada
19 de julio de 2019NDA212516 Duloxetine
DRIZALMA SPRINKLE
Sun Pharm
12 de julio de 2019ANDA208994 Technescan tc 99M mertiatide
TECHNETIUM TC99M MERTIATIDE KIT
Sun Pharm Inds Inc
1 de julio de 2019ANDA205467 Febuxostat
FEBUXOSTAT
Sun Pharm
26 de junio de 2019ANDA210191 Dapsone
DAPSONE
Sun Pharma Canada
21 de junio de 2019ANDA204668 Capecitabine
CAPECITABINE
Sun Pharm
21 de mayo de 2019ANDA208292 Dalfampridine
DALFAMPRIDINE
Sun Pharm
1 de mayo de 2019ANDA210760 Medroxyprogesterone acetate
MEDROXYPROGESTERONE ACETATE
Sun Pharm
26 de abril de 2019ANDA209324 Bosentan
BOSENTAN
Sun Pharm
24 de abril de 2019ANDA210761 Medroxyprogesterone acetate
MEDROXYPROGESTERONE ACETATE
Sun Pharm
15 de abril de 2019ANDA210978 Clobazam
CLOBAZAM
Taro
10 de abril de 2019ANDA208201 Naftifine hydrochloride
NAFTIFINE HYDROCHLORIDE
Sun Pharma Canada
28 de marzo de 2019ANDA210784 Ambrisentan
AMBRISENTAN
Sun Pharm
26 de marzo de 2019ANDA208934 Tadalafil
TADALAFIL
Sun Pharm
1 de marzo de 2019ANDA209430 Dapsone
DAPSONE
Taro
21 de febrero de 2019ANDA204556 Calcitriol
CALCITRIOL
Sun Pharm
8 de febrero de 2019ANDA208800 Deferiprone
DEFERIPRONE
Taro
25 de enero de 2019ANDA211644 Tretinoin
TRETINOIN
Sun Pharma Canada
25 de enero de 2019ANDA211858 Mesalamine
MESALAMINE
Sun Pharm
22 de enero de 2019ANDA211645 Tretinoin
TRETINOIN
Sun Pharma Canada
4 de enero de 2019ANDA208066 Lurasidone hydrochloride
LURASIDONE HYDROCHLORIDE
Sun Pharm
21 de noviembre de 2018ANDA211477 Fluoxetine
FLUOXETINE HYDROCHLORIDE
Somerset Theraps LLC
5 de noviembre de 2018ANDA207820 Levalbuterol
LEVALBUTEROL HYDROCHLORIDE
Sun Pharm
17 de octubre de 2018ANDA209148 Adapalene and benzoyl peroxide
ADAPALENE AND BENZOYL PEROXIDE
Sun Pharma Canada
11 de octubre de 2018ANDA207008 Cinacalcet
CINACALCET HYDROCHLORIDE
Sun Pharm
9 de octubre de 2018ANDA210466 Dofetilide
DOFETILIDE
Sun Pharm
4 de octubre de 2018ANDA208779 Clobetasol propionate
CLOBETASOL PROPIONATE
Taro
12 de septiembre de 2018NDA206185 Latanoprost
XELPROS
Sun Pharm
14 de agosto de 2018NDA210913 Cyclosporine
CEQUA
Sun Pharm
20 de julio de 2018ANDA202803 Sumatriptan and naproxen sodium
SUMATRIPTAN AND NAPROXEN SODIUM
Sun Pharm
5 de junio de 2018ANDA208683 Clindamycin phosphate and benzoyl peroxide
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
Sun Pharma Canada
22 de mayo de 2018NDA210308 Abiraterone acetate
YONSA
Sun Pharm
8 de mayo de 2018ANDA201691 Hydroxychloroquine sulfate
HYDROXYCHLOROQUINE SULFATE
Alkaloida Zrt
30 de abril de 2018ANDA209735 Esomeprazole
ESOMEPRAZOLE MAGNESIUM
Sun Pharm
6 de abril de 2018ANDA205618 Paliperidone
PALIPERIDONE
Sun Pharm
26 de marzo de 2018ANDA208842 Clobetasol propionate
CLOBETASOL PROPIONATE
Sun Pharma Canada
20 de marzo de 2018BLA761067 Tildrakizumab-asmn
ILUMYA
Sun Pharma Global
26 de enero de 2018NDA210428 Metoprolol
KAPSPARGO SPRINKLE
Spil
24 de enero de 2018ANDA206959 Adapalene and benzoyl peroxide
ADAPALENE AND BENZOYL PEROXIDE
Sun Pharma Canada
15 de diciembre de 2017ANDA206218 Clindamycin phosphate and benzoyl peroxide
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
Sun Pharma Canada
25 de octubre de 2017ANDA090132 Carvedilol
CARVEDILOL PHOSPHATE
Sun Pharm Industries
16 de octubre de 2017ANDA209506 Dapsone
DAPSONE
Sun Pharma Canada
7 de agosto de 2017ANDA207875 Ipratropium bromide and albuterol sulfate
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE
Sun Pharm
21 de julio de 2017ANDA207857 Albuterol sulfate
ALBUTEROL SULFATE
Sun Pharm
23 de junio de 2017ANDA209204 Ibuprofen
IBUPROFEN
Sun Pharma Canada
16 de junio de 2017ANDA206314 Felbamate
FELBAMATE
Taro
8 de junio de 2017ANDA203023 Diltiazem
DILTIAZEM HYDROCHLORIDE
Sun Pharm

Se muestran las 125 más recientes de 344 solicitudes. Listas completas: Drugs@FDA →

El patrocinador es la empresa titular de la solicitud ante la FDA; puede ser distinta de la etiquetadora.

Cronología de retiros

2026

  1. 29 de mayo de 2026 · Clase II · En curso · D-0607-2026 · Budesonide

    Presence of Foreign Substance:This recall has been initiated in response to a product quality complaint reported for black/brown specs and particles within the ampoule solution

    Budesonide Inhalation Suspension, 1mg/2mL, 30 x 2 mL Sterile Single-Dose Ampules (5 Single-Dose Ampules per pouch, 6 pouches per carton, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactur

2025

  1. 3 de septiembre de 2025 · Clase II · En curso · D-0658-2025 · Technescan tc 99M mertiatide

    Failed Dissolution Specifications-Out of Specification (OOS) observation for sulphate in Sodium Tartrate Dihydrate used for the production of Mertiatide.

    Kit for the Preparation of Technetium Tc 99m Mertiatide, Rx Only, Manufactured by: Sun Pharmaceutical Industries, Inc. Billerica, MA 01821, NDC 45567-0655-1

  2. 5 de agosto de 2025 · Clase II · En curso · D-0574-2025 · Spironolactone

    Presence of foreign substance: identified as aluminum.

    Spironolactone Tablets, USP, 25 mg, 100-count bottle, Rx only, Mfg. by: Frontida BioPharm, Inc., 1100 Orthodox St, Philadelphia, PA 19124, Dist. by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 53489-143-

  3. 4 de marzo de 2025 · Clase III · En curso · D-0311-2025 · Gabapentin

    Cross Contamination

    Gabapentin Capsules, USP 300 mg, Rx Only, Packaged in a) 500-count bottles, NDC 62756-138-05; b) 1000-count bottles, NDC 62756-138-04, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured

  4. 4 de marzo de 2025 · Clase III · En curso · D-0312-2025 · Gabapentin

    Cross Contamination

    Gabapentin Capsules, USP 400 mg, Rx Only, Packaged in a) 500-count bottles, NDC 62756-139-05; b) 1000-count bottles, NDC 62756-139-04; Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured

  5. 6 de febrero de 2025 · Clase II · En curso · D-0249-2025 · Morphine sulfate

    Failed Dissolution Specifications

    Morphine Sulfate Extended-Release Tablets, 100 mg, 100-count bottles, Rx Only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901. Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512. NDC

2024

  1. 22 de abril de 2024 · Clase III · En curso · D-0502-2024 · Latanoprost

    Failed Release Testing: Out of specification for particulate matter test.

    Xelpros (latanoprost ophthalmic emulsion) 0.005%, 125mcg/2.5mL, 2.5 mL bottle, Rx only, Manufactured by: Sun Pharmaceutical Ind. Ltd., India., NDC 47335-317-90

  2. 19 de abril de 2024 · Clase II · En curso · D-0493-2024 · Amphotericin b

    Out of specification for assay

    Amphotericin B Liposome for Injection, 50mg vials, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Medicare Limited, Baska Ujeti Road, Ujeti Halol-3893

  3. 5 de febrero de 2024 · Clase II · En curso · D-0350-2024 · Mesalamine

    Failed Dissolution Specifications: Out of specification for dissolution.

    Mesalamine Extended-Release Capsules, USP 500mg, Rx Only, 120 Capsules per bottle, Manufactured by: Sun Pharmaceutical Industries Limited, Mohali, INDIA, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ

  4. 18 de enero de 2024 · Clase II · Completado · D-0271-2024 · Zolpidem tartrate

    CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

    Zolpidem Tartrate Extended-Release Tablets, USP 6.25 mg, Rx Only, 100 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, S

Mostrar los 50 retiros anteriores

2024

  1. 18 de enero de 2024 · Clase II · Completado · D-0270-2024 · Niacin

    CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

    Niacin Extended-Release Tablets, USP 500mg, Rx Only, 90 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Survey No. 259/

  2. 18 de enero de 2024 · Clase II · Completado · D-0265-2024 · Febuxostat

    CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

    Febuxostat Tablets 80 mg, Rx Only, 30 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd., Survey No. 259/15, Dadra-396 191, (U

  3. 18 de enero de 2024 · Clase II · Completado · D-0264-2024 · Febuxostat

    CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

    Febuxostat Tablets 40mg, Rx Only, 30 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd., Survey No. 259/15, Dadra-396 191 (U.T

  4. 18 de enero de 2024 · Clase II · Completado · D-0263-2024 · Cinacalcet

    CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

    Cinacalcet Tablets 60mg, Rx Only, 30 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited Survey No. 259/15, Dadra-396 191 (U

  5. 18 de enero de 2024 · Clase II · Completado · D-0268-2024 · Mesalamine

    CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

    Mesalamine Delayed-Release Tablets, USP 1.2 g per tablet, Rx Only, 120 Tablets per bottle, Once Daily, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industri

  6. 18 de enero de 2024 · Clase II · Completado · D-0269-2024 · Niacin

    CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

    Niacin Extended-Release Tablets, USP 1000mg, Rx Only, 90 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Survey No. 259

  7. 18 de enero de 2024 · Clase II · Completado · D-0272-2024 · Zolpidem tartrate

    CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

    Zolpidem Tartrate Extended-Release Tablets, USP 12.5mg, Rx Only, 100 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Su

  8. 18 de enero de 2024 · Clase II · Completado · D-0266-2024 · Lurasidone hydrochloride

    CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

    Lurasidone Hydrochloride Tablets 60mg, Rx Only, 30 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd., Survey No. 259/15, Dadr

  9. 18 de enero de 2024 · Clase II · Completado · D-0267-2024 · Lurasidone hydrochloride

    CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

    Lurasidone Hydrochloride Tablets 120mg, Rx Only, 30 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd., Survey No. 259/15, Dad

2023

  1. 4 de diciembre de 2023 · Clase II · Cerrado por la FDA · D-0150-2024 · Liothyronine sodium

    Failed Impurities/Degradation Specifications

    Liothyronine Sodium Tablets, USP 5 mcg, 100-count bottle, Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396 1

  2. 20 de octubre de 2023 · Clase II · Cerrado por la FDA · D-0083-2024 · Liothyronine sodium

    Failed Impurities/Degradation Specifications.

    Liothyronine Sodium Tablets, USP, 5 mcg, 100-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc.Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396

  3. 20 de octubre de 2023 · Clase II · Cerrado por la FDA · D-0084-2024 · Liothyronine sodium

    Failed Impurities/Degradation Specifications.

    Liothyronine Sodium Tablets, USP, 25 mcg, 100-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc.Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-39

  4. 7 de septiembre de 2023 · Clase III · Cerrado por la FDA · D-1172-2023 · Cyclosporine

    Subpotent: Out of Specification result observed for low assay

    Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), Rx only, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, Coutances, France NDC 47335-5

  5. 18 de julio de 2023 · Clase III · Cerrado por la FDA · D-1082-2023 · Dofetilide

    Out of Specification result observed in content uniformity testing

    Dofetilide Capsules 500 mcg (0.5mg), 60-count bottle, Rx Only, Manufactured by Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191, (U.T of D & NH), India, Distributed by: Sun Pharmaceutical Industrie

  6. 10 de julio de 2023 · Clase II · Cerrado por la FDA · D-0914-2023 · Tiagabine hydrochloride

    Failed Impurities: Out of Specification (OOS) result observed during Related Substances testing

    Tiagabine Hydrochloride Tablets, 2 mg, 30-count bottle, Distributed by Sun Pharmaceutical Industries. Inc. Cranbury NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited Halol-Baroda Highway, Halol-389 350, Gu

  7. 5 de julio de 2023 · Clase III · Cerrado por la FDA · D-0924-2023 · Loteprednol etabonate

    Superpotent Drug: Out of Specification (OOS) results observed for unit dose content.

    Loteprednol Etabonate Ophthalmic Suspension, 5 mg/mL (0.5%), packaged as one bottle in a carton in a) 10 mL bottle (NDC# 62756-232-55) and b) 15 mL bottle (NDC # 62756-232-56), Rx only, Distributed by: Sun Pharmaceutical

  8. 3 de mayo de 2023 · Clase II · Cerrado por la FDA · D-0869-2023 · Buprenorphine

    CGMP Deviations

    Buprenorphine Sublingual Tablets, 8 mg, 30 count-bottles, Rx only, Manufactured by: Sun Pharma, NDC 62756-460-83.

  9. 13 de enero de 2023 · Clase II · Cerrado por la FDA · D-0262-2023 · Diltiazem

    Failed Impurity (Deacetyl Diltiazem Hydrochloride) specification during stability testing and failed dissolution testing at FDA laboratory.

    Diltiazem Hydrochloride Extended-Release Capsules, USP, 360 mg; Rx only; 90-count bottles, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389350, Gujarat, India; Distributed by: Sun Pharm

2022

  1. 1 de diciembre de 2022 · Clase II · Cerrado por la FDA · D-0085-2023 · Oxcarbazepine

    Presence of foreign substance

    Oxcarbazepine Tablets 600mg, packaged in a) 100- count bottles (NDC 62756-185-88), b) 500-count bottles (NDC 62756-185-13), c)1000-count bottles (NDC 62756-185-18), Rx Only, Distributed by: Sun Pharmaceutical Industries,

  2. 18 de octubre de 2022 · Clase II · Cerrado por la FDA · D-0024-2023 · Buprenorphine and naloxone

    Presence of Foreign Substance

    Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg, 30-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 25

  3. 25 de julio de 2022 · Clase II · Cerrado por la FDA · D-0068-2023 · Pantoprazole sodium

    Discoloration

    Pantoprazole Sodium for Delayed-Release Oral Suspension*40 mg* suspension in apple juice or applesauce only Each packet contains 40 mg pantoprazole equivalent to 45.1 mg of pantoprazole sodium USP (sesquihydrate), Rx Onl

  4. 27 de junio de 2022 · Clase II · Cerrado por la FDA · D-1291-2022 · Divalproex sodium

    Failed Dissolution Specifications: Failure occurred during routine stability testing of dissolution test.

    Divalproex Sodium Delayed-Release Tablets, USP 500mg, Rx Only, 100 Tablets, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries, Ltd., Halol-Baroda High

  5. 21 de junio de 2022 · Clase III · Cerrado por la FDA · D-0005-2023 · Esomeprazole

    Superpotent Drug: Out of specification for assay at the 12-month timepoint.

    Esomeprazole Magnesium Delayed-Release Capsules, USP, 40mg, Rx Only, 90 Capsules per bottle, Manufactured by: Ohm Laboratories Inc. New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, N

  6. 21 de junio de 2022 · Clase III · Cerrado por la FDA · D-0004-2023 · Esomeprazole

    Superpotent Drug: Out of specification for assay at the 12-month timepoint.

    Esomeprazole Magnesium Delayed-Release Capsules, USP 20mg, Rx Only, 90 Capsules per bottle, Manufactured by: Ohm Laboratories Inc. New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ

  7. 21 de junio de 2022 · Clase II · Cerrado por la FDA · D-1190-2022 · Testosterone cypionate

    cGMP - Water leakage

    Testosterone Cypionate Injection, USP, 200mg/mL, CIII, Rx only, 1mL Single-dose vial, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceuticals Industries Ltd., Halol-

  8. 10 de junio de 2022 · Clase II · Cerrado por la FDA · D-1154-2022 · Testosterone cypionate

    Lack of Assurance of Sterility: Manufacturing deviation which was reported due to a microbial excursion

    Testosterone Cypionate Injection, USP, 200 mg/mL, 1 mL Single-dose vial per carton, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; Manufactured by: Sun Pharmaceutical Industries Ltd., H

  9. 3 de junio de 2022 · Clase II · Cerrado por la FDA · D-1153-2022 · Testosterone cypionate

    CGMP Deviations: lots made with same active pharmaceutical ingredient (API) as lots that were rejected due to manufacturing issues that could cause the product to be out of specification for impurities.

    Testosterone Cypionate Injection, USP, 200 mg/mL, 1 mL Single-dose vial per carton, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; Manufactured by: Sun Pharmaceutical Industries Ltd., H

  10. 3 de junio de 2022 · Clase II · Cerrado por la FDA · D-1176-2022 · Testosterone cypionate

    CGMP Deviations: Manufacturing deviations were reported due to an abnormal appearance on parts of machinery.

    Testosterone Cypionate Injection, USP, 200mg/ml, Rx Only, One Single-dose vial, Distributed by: Sun Pharmaceutical Industries Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceuticals Industries Ltd., Halol-Baroda H

  11. 6 de mayo de 2022 · Clase II · Cerrado por la FDA · D-1145-2022 · Medroxyprogesterone acetate

    Lack of assurance of sterility

    medroxyPROGESTERone Acetate Injectable Suspension, USP, 1 mL Prefilled Syringe, 150 mg/mL, Rx only, Manufactured by Sun Pharmaceutical Industries Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India, Distributed by:

  12. 13 de abril de 2022 · Clase II · Cerrado por la FDA · D-1032-2022 · Doxycycline

    cGMP deviations: Temperature abuse

    Doxycycline Capsules, USP, 100 mg, 50-count bottle, Rx only, Distributed by: Sun Pharmaceuticals, NDC 63304-616-50

  13. 13 de abril de 2022 · Clase II · Cerrado por la FDA · D-1111-2022 · Sumatriptan

    cGMP deviations: Temperature abuse

    Sumatriptan Succinate Tablets, 100 mg, 9 (1 x 9) Unit-of- use tablets box, Rx only, MFG: Sun Pharmaceuticals, NDC 62756-522-69

  14. 1 de abril de 2022 · Clase III · Cerrado por la FDA · D-0770-2022 · Cyclosporine

    Subpotent Drug and Presence of Particulate Matter: low out-of-specification results obtained for assay and the presence of particulate matter.

    Cequa (cyclosporine ophthalmic solution) 0.09%, packaged in 6 pouches x 10 single-use vials (0.25 mL each) per box, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, ZI de la Guerie, F-50211 Coutances Cedex

2021

  1. 22 de octubre de 2021 · Clase II · Cerrado por la FDA · D-0361-2022 · Pregabalin

    Failed Tablet/Capsule Specifications: Out of Specification results for particle Size Distribution and Bulk Density of the Active Pharmaceutical Ingredient.

    Pregabalin Capsules, 50 mg, 100 count bottle, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd., Survey No. 259/15 Dadra-396 191, (U.T.

  2. 7 de mayo de 2021 · Clase III · Cerrado por la FDA · D-0391-2021 · Cyclosporine

    Subpotent and Presence of Particulates .

    Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), Rx only, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, Coutances, France Distributed

  3. 4 de mayo de 2021 · Clase II · Cerrado por la FDA · D-0372-2021 · Metformin hydrochloride

    Presence of foreign substance: identified as activated carbon.

    Metformin HCl Extended-Release Tablets, USP, 500 mg, packaged in 500-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd., Ha

  4. 25 de marzo de 2021 · Clase III · Cerrado por la FDA · D-0325-2021 · Metformin hydrochloride

    Failed Moisture Limits: Out of specification for water content

    Metformin HCl Extended-Release Tablets, USP, 500 mg, Rx Only, 500-count bottle, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; Manufactured by: Sun Pharmaceutical Industries Ltd., Halol

  5. 15 de marzo de 2021 · Clase II · Cerrado por la FDA · D-0568-2021 · Clindamycin

    CGMP Deviations: Intermittent exposure to temperature excursion during storage.

    CLINDAMYCIN HYDROCHLORIDE CAPSULES, USP,150MG 100-count bottles, Rx Only, Manufactured by: Ohm Laboratories Inc. New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 63304-

  6. 22 de febrero de 2021 · Clase III · Cerrado por la FDA · D-0289-2021 · Cyclosporine

    Subpotent

    Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), Rx only, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, Coutances, France NDC 47335-5

  7. 5 de febrero de 2021 · Clase III · Cerrado por la FDA · D-0251-2021 · Pantoprazole sodium

    Failed Impurity/Degradation Specifications

    Pantoprazole Sodium for Injection 40mg/vial For I.V. infusion only Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-38

  8. 11 de enero de 2021 · Clase III · Cerrado por la FDA · D-0242-2021 · Testosterone cypionate

    Incorrect Labeling: Incorrect lot number on secondary packaging

    Testosterone Cypionate Injection, USP CIII 200mg/ml FOR INTRAMUSCULAR USE ONLY 1mL Single-dose vial Distributed by: Sun Pharma Ind. Inc, NJ 08512 Manufactured by: Sun Pharma Ind. Ltd., India NDC 62756-015-40

2020

  1. 13 de marzo de 2020 · Clase II · Cerrado por la FDA · D-1032-2020 · Doxycycline

    CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.

    Doxycycline Capsules, USP, 75 mg, 100-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901; Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 63304-615-01.

  2. 13 de marzo de 2020 · Clase II · Cerrado por la FDA · D-1033-2020 · Doxycycline

    CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.

    Doxycycline Capsules, USP, 100 mg, 50-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901; Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 63304-616-50.

  3. 14 de enero de 2020 · Clase II · Cerrado por la FDA · D-0787-2020 · Testosterone cypionate

    cGMP Deviations; released lots were manufactured under similar manufacturing conditions to a previously rejected OOS Lot.

    Testosterone Cypionate for Injection, USP, 1,000 mg/10 mL (100 mg/mL), 10 mL Multiple Dose Vial (NDC 62756-017-40), Rx only, Distributed by: Sun Pharmaceuticals, Inc., Cranbury, NJ, Manufactured by: Sun Pharmaceuticals,

  4. 14 de enero de 2020 · Clase II · Cerrado por la FDA · D-0788-2020 · Testosterone cypionate

    cGMP Deviations; released lots were manufactured under similar manufacturing conditions to a previously rejected OOS Lot.

    Testosterone Cypionate for Injection, 2,000 mg/10 mL (200 mg/mL), a) 1 mL Single Use vial (NDC 62756-015-40) and b) 10 mL Multiple Dose Vial (NDC 62756-016-40), Rx only, Distributed by: Sun Pharmaceuticals, Inc., Cranbur

2019

  1. 26 de diciembre de 2019 · Clase II · Cerrado por la FDA · D-0659-2020 · Sumatriptan

    Failed Impurities/Degradation Specifications; out-of-specification results obtained for related substance.

    Sumatriptan Succinate Tablets, 50 mg, packaged in a) 9 (1x9) Unit-of use blister card (NDC 62756-521-69) and b) 100 count bottles, (NDC 62756-521-88), Rx only, Sun Pharma, Cranbury, NJ

  2. 24 de enero de 2019 · Clase II · Cerrado por la FDA · D-0422-2019 · Bromfenac

    Bromfenac Ophthalmic Solution, 0.075% (Sterile 5 mL) may have a lack of sterility assurance.

    BromSite (bromfenac ophthalmic solution) 0.075%, 5 mL bottles, Rx Only, Distributed by : Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 49708-754-41

  3. 3 de enero de 2019 · Clase I · Cerrado por la FDA · D-0373-2019 · Vecuronium bromide

    Presence of Particulate Matter: Foreign matter identified as glass detected in Vecuronium Bromide for Injection.

    Vecuronium Bromide for Injection 20 mg* *1mg/mL when reconstituted to 20 mL Lyophilized, 10 x 20 mg vials, Rx Only, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway Halol-389 350, Gujarat, India.

  4. 3 de enero de 2019 · Clase I · Cerrado por la FDA · D-0372-2019 · Vecuronium bromide

    Presence of Particulate Matter: Foreign matter identified as glass detected in Vecuronium Bromide for Injection.

    Vecuronium Bromide for Injection 10 mg*, *1mg/mL when reconstituted to 10 mL Lyophilized, 10 x 10 mg vials, Rx only, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway Halol-389 350, Gujarat, India.

2018

  1. 7 de diciembre de 2018 · Clase III · Cerrado por la FDA · D-1207-2019 · Isotretinoin

    Subpotent Drug: Isotretinoin content results were lower than the specification limit obtained during routing product monitoring.

    Absorica (Isotretinoin) Capsules 30 mg USP, 30 capsules (3x10 Prescription Packs) Rx only, Manufactured by: Galephar Pharmaceutical Research Inc. Humacao, PR 00792, Distributed by: Sun Pharmaceutical Industries Inc. Cran

  2. 12 de julio de 2018 · Clase II · Cerrado por la FDA · D-0977-2018 · Testosterone cypionate

    Presence of Particulate Matter: organic and inorganic compounds detected in vials of product.

    Testosterone Cypionate Injection, USP, 200 mg/mL, Rx only, 10 mL vials, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries, Ltd., Halol-Baroda Highway,

Se muestran los 60 más recientes de 72.

¿Qué significan las clases de retiro?

Clase I: El tipo más grave: existe una probabilidad razonable de que usar el producto cause problemas de salud graves o la muerte.
Clase II: Usar el producto puede causar problemas de salud temporales o reversibles con tratamiento, o la probabilidad de problemas graves es remota.
Clase III: No es probable que usar el producto cause problemas de salud (por ejemplo, un problema de etiquetado o de envase).

Fuentes

  1. NDC Directory (openFDA) — Administración de Alimentos y Medicamentos de los EE. UU. (FDA), datos de la FDA exportados el 30 de octubre de 2026, consultados el 31 de octubre de 2026
  2. Drugs@FDA (openFDA) — Administración de Alimentos y Medicamentos de los EE. UU. (FDA), datos de la FDA exportados el 30 de octubre de 2026, consultados el 31 de octubre de 2026
  3. Drug recall enforcement reports (openFDA) — Administración de Alimentos y Medicamentos de los EE. UU. (FDA), datos de la FDA exportados el 27 de octubre de 2026, consultados el 31 de octubre de 2026

Buscador de informes de retiros de la FDA → · Informar un error →